Paclitaxel-induced Peripheral Neuropathy and Quality of Life: Sub-analysis of the MICHEL Study
Paclitaxel administration affected activities of daily living through CIPN and symptoms were primarily noted in the hands and feet with regard to fine motor hand movements and mobility. Individualized care, potentially with duloxetine or rehabilitation exercises (in addition to self-care education), may be considered stopgap measures.
Authors
- Tomohei Matsuo (ORCID: https://orcid.org/0000-0001-5630-5100)
- Mai Okazaki
- Akiko Iguchi‐Manaka (ORCID: https://orcid.org/0000-0002-0338-130X)
- Takeshi Machino (ORCID: https://orcid.org/0000-0002-9010-2857)
- Takeshi Yamada (ORCID: https://orcid.org/0000-0002-6490-758X)
- Bryan J. Mathis (ORCID: https://orcid.org/0000-0002-9879-8289)
- Hiroko Bando (ORCID: https://orcid.org/0000-0002-7361-3647)
- Aya Sawa
- Riko Sato (ORCID: https://orcid.org/0000-0002-2227-8332)
- Sachie Hashimoto (ORCID: https://orcid.org/0000-0001-5973-9051)
- K. Shimada
Institutions
- University of Tsukuba (JP)
- University of Tsukuba Hospital (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-08-28
- DOI
- https://doi.org/10.21873/anticanres.17742
- Citations
- 2
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 2.09